32944 Federal Register / Vol. 74, No. 130 / Thursday, July 9, 2009 / Notices 

Reviews was established to aid the Advisory 

Board in carrying out its duty to advise the 

Secretary, HHS, on dose reconstruction. It is 

responsible for overseeing, tracking, and 

participating in the reviews of all procedures 

used in the dose reconstruction process by 

the NIOSH Office of Compensation Analysis 

and Support (OCAS) and its dose 

reconstruction contractor. 

Matters To Be Discussed: The agenda for 

the Subcommittee meeting includes: 

preparation of status report to the Secretary 

on procedures review; a discussion of SC&A 

Findings and NIOSH Responses on OCAS– 

IG–004 (‘‘The Use of Data from Other 

Facilities in the Completion of Dose 

Reconstructions under EEOICPA’’) 

concerning the use of ‘‘surrogate data’’; 

discussion of the following ORAU 

procedures: OTIB–0035 (‘‘Internal Dosimetry 

Co-worker Data for K–25’’), OTIB–0052 

(‘‘Parameters to Consider when Processing 

claims for Construction Trades Workers’’), 

OTIB–0047 (External Radiation monitoring at 

Y–12 During the 1948–1949 Period’’), and 

OTIB–0049 (‘‘Estimating Doses for Plutonium 

Strongly Retained in the Lung’’); and, a 

continuation of the comment-resolution 

process for other dose reconstruction 

procedures under review by the 

Subcommittee. 

The agenda is subject to change as 

priorities dictate. 

This meeting is open to the public, but 

without a public comment period. In the 

event an individual wishes to provide 

comments, written comments may be 

submitted. Any written comments received 

will be provided at the meeting and should 

be submitted to the contact person below in 

advance of the meeting. 

For More Information Contact: Theodore 

Katz, Executive Secretary, NIOSH, CDC, 1600 

Clifton Road, Mailstop E–20, Atlanta GA 

30333, Telephone (513) 533–6800, Toll Free 

1(800) CDC–INFO, E-mail ocas@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: July 2, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–16226 Filed 7–8–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Board on Radiation and 

Worker Health (ABRWH or Advisory 

Board), National Institute for 

Occupational Safety and Health 

(NIOSH) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), and pursuant to the 

requirements of 42 CFR 83.15(a), the 

Centers for Disease Control and 

Prevention (CDC), announces the 

following meeting of the 

aforementioned committee: 

Board Public Meeting Times and Dates: 

(All times are Eastern Time): 

1:30 p.m.–5:45 p.m., July 27, 2009. 

9 a.m.–5:30 p.m., July 28, 2009. 

9 a.m.–3 p.m., July 29, 2009. 

Public Comment Times And Dates: (All 

times are Eastern Time): 

7 p.m.–8 p.m., July 27, 2009. 

5:45 p.m.–6:30 p.m., July 28, 2009. 

Place: Cincinnati Marriott North at Union 

Centre, 6189 Muhlhauser Road, West 

Chester, Ohio; Phone: (800) 228–9290; Fax: 

(513) 645–4619. The USA toll free dial in 

number is 1–866–659–0537 with a pass code 

of 9933701. 

Status: Open to the public, limited only by 

the space available. The meeting space 

accommodates approximately 100 people. 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation Program 

(EEOICP) Act of 2000 to advise the President 

on a variety of policy and technical functions 

required to implement and effectively 

manage the new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines which 

have been promulgated by the Department of 

Health and Human Services HHS) as a final 

rule, advice on methods of dose 

reconstruction which have also been 

promulgated by HHS as a final rule, advice 

on the scientific validity and quality of dose 

estimation and reconstruction efforts being 

performed for purposes of the compensation 

program, and advice on petitions to add 

classes of workers to the Special Exposure 

Cohort (SEC). In December 2000, the 

President delegated responsibility for 

funding, staffing, and operating the Advisory 

Board to HHS, which subsequently delegated 

this authority to the CDC. NIOSH implements 

this responsibility for CDC. The charter was 

issued on August 3, 2001, renewed at 

appropriate intervals, and will expire on 

August 3, 2009. 

Purpose: This Advisory Board is charged 

with (a) providing advice to the Secretary, 

HHS, on the development of guidelines 

under Executive Order 13179; (b) providing 

advice to the Secretary, HHS, on the 

scientific validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advise the Secretary on 

whether there is a class of employees at any 

Department of Energy facility who were 

exposed to radiation but for whom it is not 

feasible to estimate their radiation dose, and 

on whether there is reasonable likelihood 

that such radiation doses may have 

endangered the health of members of this 

class. 

Matters To Be Discussed: The agenda for 

the Advisory Board meeting includes: Ethics 

training for Board members; NIOSH Program 

Status Update; Department of Labor (DOL) 

Update; Department of Energy (DOE) Update; 

Mound Working Group Update; Special 

Exposure Cohort (SEC) Petitions for: Oak 

Ridge Hospital, Baker-Perkins Company, 

Lake Ontario Ordinance Works, Bliss and 

Laughlin Steel, Norton Company, Blockson 

Chemical Company (regarding radon-related 

dose reconstruction), Dow Chemical 

Company (Madison, Illinois), and Chapman 

Valve Manufacturing Company; OCAS 

Science Update; Dose Reconstruction 

Program Report; Special Exposure Cohort 

(SEC) Petition Status Updates; Work Group 

reports; Reports of the Subcommittees on 

Dose Reconstruction Reviews and Procedures 

Reviews; and Board Working Time. 

The agenda is subject to change as 

priorities dictate. 

In the event an individual cannot attend, 

written comments may be submitted 

according to the policy provided below. Any 

written comments received will be provided 

at the meeting and should be submitted to 

the contact person below well in advance of 

the meeting. 

Policy on Redaction of Board Meeting 

Transcripts (Public Comment), (1) If a person 

making a comment gives his or her name, no 

attempt will be made to redact that name. (2) 

NIOSH will take reasonable steps to ensure 

that individuals making public comment are 

aware of the fact that their comments 

(including their name, if provided) will 

appear in a transcript of the meeting posted 

on a public website. Such reasonable steps 

include: (a) A statement read at the start of 

each public comment period stating that 

transcripts will be posted and names of 

speakers will not be redacted; (b) A printed 

copy of the statement mentioned in (a) above 

will be displayed on the table where 

individuals sign up to make public comment; 

(c) A statement such as outlined in (a) above 

will also appear with the agenda for a Board 

Meeting when it is posted on the NIOSH 

website; (d) A statement such as in (a) above 

will appear in the Federal Register Notice 

that announces Board and Subcommittee 

meetings. (3) If an individual in making a 

statement reveals personal information (e.g., 

medical information) about themselves that 

information will not usually be redacted. The 

NIOSH FOIA coordinator will, however, 

review such revelations in accordance with 

the Freedom of Information Act and the 

Federal Advisory Committee Act and if 

deemed appropriate, will redact such 

information. (4) All disclosures of 

information concerning third parties will be 

redacted. (5) If it comes to the attention of the 

DFO that an individual wishes to share 


rmajette on DSK29S0YB1 with NOTICES
Federal Register / Vol. 74, No. 130 / Thursday, July 9, 2009 / Notices 32945 

information with the Board but objects to 

doing so in a public forum, the DFO will 

work with that individual, in accordance 

with the Federal Advisory Committee Act, to 

find a way that the Board can hear such 

comments. 

Contact Person for More Information: 

Theodore Katz, M.P.A., Executive Secretary, 

NIOSH, CDC, 1600 Clifton Road, MS E–20, 

Atlanta GA 30333, Telephone (513) 533– 

6800, Toll Free 1 (800) CDC–INFO, E-mail 

ocas@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: July 2, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–16223 Filed 7–8–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, August 

6, 2009, 1 p.m. to August 6, 2009, 4 

p.m., Sheraton Delfina Hotel, 530 West 

Pico Boulevard, Santa Monica, CA, 

90405 which was published in the 

Federal Register on June 8, 2009, 74 FR 

27156–27160. 

The meeting has been changed to a 

telephone conference at the National 

Institutes of Health, 6701 Rockledge 

Drive, Bethesda, MD 20892. The 

meeting date and time remain the same. 

The meeting is closed to the public. 

Dated: June 30, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–16116 Filed 7–8–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel P–30 Faculty Recruitment 1. 

Date: July 23, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Monaco, 501 Geary St., San 

Francisco, CA 94102. 

Contact Person: Phillip F. Wiethorn, 

Scientific Review Administrator, DHHS/NIH/ 

NINDS/DER/SRB, 6001 Executive Boulevard; 

MSC 9529, Neuroscience Center; Room 3203, 

Bethesda, MD 20892–9529, (301) 496–5388, 

wiethorp@ninds.nih.gov. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel P–30 Faculty Recruitment 2. 

Date: July 28, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Ritz Carlton Hotel, 1150 22nd Street, 

NW., Washington, DC 20037. 

Contact Person: Phillip F. Wiethorn, 

Scientific Review Administrator, DHHS/NIH/ 

NINDS/DER/SRB, 6001 Executive Boulevard; 

MSC 9529, Neuroscience Center; Room 3203, 

Bethesda, MD 20892–9529, (301) 496–5388, 

wiethorp@ninds.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences; 93.701, ARRA Related 

Biomedical Research and Research Support 

Awards, National Institutes of Health, HHS) 

Dated: June 30, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–16107 Filed 7–8–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel. Health and 

Retirement Across Nations. 

Date: July 28, 2009. 

Time: 11 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Suite 2C212, Bethesda, MD 20814. 

(Telephone Conference Call). 

Contact Person: Rebecca J. Ferrell, PhD, 

Scientific Review Officer, National Institute 

on Aging, Gateway Building 2C212, 7201 

Wisconsin Avenue, Bethesda, MD 20814. 

301–402–7703. ferrellrj@mail.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Effect of 

Energy Flux on Risk Factors for Age-Related 

Chronic Diseases. 

Date: July 30, 2009. 

Time: 12 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

2C212, Bethesda, MD 20814 (Telephone 

Conference Call). 

Contact Person: Ramesh Vemuri, PhD, 

Chief, Scientific Review Branch, National 

Institute on Aging, National Institutes of 

Health, 7201 Wisconsin Avenue, Suite 2C– 

212, Bethesda, MD 20892. 301–402–7700. 

rv23r@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: June 30, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–16105 Filed 7–8–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Cancer 

Institute Special Emphasis Panel, 

August 5, 2009, 8 a.m. to August 6, 

2009, 5 p.m., Marriott Bethesda North 

Hotel and Conf. Ctr., Bethesda, MD 

which was published in the Federal 

Register on June 26, 2009, 74FR30592. 


rmajette on DSK29S0YB1 with NOTICES